Multivariate Cox regression analysis revealed that TREM1 expression was still an independent predictor for glioma patients (HR: 1.046; 95% CI: 1.019-1.117; P =0.045) after adjusting for the clinical factors mentioned above (Supplementary Table S1). This evidence concerns the gene TREM1 and central nervous system cancer.